A multicentre point prevalence study of antibiotics utilization in hospitalized patients in an urban secondary and a tertiary healthcare facilities in Nigeria: findings and implications.


Journal

Expert review of anti-infective therapy
ISSN: 1744-8336
Titre abrégé: Expert Rev Anti Infect Ther
Pays: England
ID NLM: 101181284

Informations de publication

Date de publication:
Feb 2022
Historique:
pubmed: 16 6 2021
medline: 22 4 2022
entrez: 15 6 2021
Statut: ppublish

Résumé

The understanding of antimicrobial utilization patterns is pertinent to successful implementation of the National Action Plans on Antimicrobial Resistance (AMR). There is, however, limited information on antibiotics utilization in Nigeria. This study was undertaken to build on existing information and provide direction for appropriate interventions including Antibiotics Stewardship Programs (ASP). A Point Prevalence Study (PPS) was conducted in two public urban health facilities in Lagos, Nigeria using a design adapted from the European Center for Disease Prevention and Control (ECDC) and Global-PPS surveys. The prevalence of antibiotics use was 80.6% administered mostly parenterally (83.1% of total prescriptions) with concerns with extended surgical antibiotics prophylaxis. The mostly used antibiotics in the secondary hospital were parenteral metronidazole (32.4%), ceftriaxone (27.5%), and amoxicillin + clavulanate (8.2%) while the mostly used in the tertiary hospital were ceftriaxone (25.3%), parenteral metronidazole (19.1%), and amoxicillin + clavulanate (9.3%). There was an appreciable lack of specific functional capacities, policies, and processes to promote appropriate antimicrobial use in both hospitals. There is high rate of antibiotics utilization in these facilities with lack of institutional frameworks and processes for ensuring appropriate antibiotic use. The study provides the information needed to improve future antimicrobial use in hospitals and reduce AMR.

Identifiants

pubmed: 34128756
doi: 10.1080/14787210.2021.1941870
doi:

Substances chimiques

Anti-Bacterial Agents 0
Anti-Infective Agents 0
Metronidazole 140QMO216E
Clavulanic Acid 23521W1S24
Ceftriaxone 75J73V1629
Amoxicillin 804826J2HU

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

297-306

Auteurs

Olayinka O Ogunleye (OO)

Department of Pharmacology, Therapeutics and Toxicology, Lagos State University College of Medicine, Ikeja, Lagos, Nigeria.
Department of Medicine, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria.

Modupe R Oyawole (MR)

Department of Pharmacy, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria.

Patricia T Odunuga (PT)

Department of Pharmacy, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria.

Folasade Kalejaye (F)

Department of Pharmacy, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria.

Adesola F Yinka-Ogunleye (AF)

Nigerian Centre for Disease Control, Federal Capital Territory, Abuja, Nigeria.
Institute of Global Health, University College, London, UK.

Adesola Olalekan (A)

Department of Medical Laboratory Science, University of Lagos, Idiaraba, Lagos, Nigeria.
Centre for Genomics of Non-Communicable Diseases and Personalized Healthcare (CGNPH), University of Lagos, Akoka, Lagos, Nigeria.

Sunday O Ogundele (SO)

Department of Pharmacology, Therapeutics and Toxicology, Lagos State University College of Medicine, Ikeja, Lagos, Nigeria.
Department of Medicine, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria.

Bernard E Ebruke (BE)

International Foundation Against Infectious Diseases In Nigeria (IFAIN), Abuja, Nigeria.

Atinuke Kalada Richard (A)

Department of Medicine, General Hospital, Lagos, Nigeria.

Bene D Anand Paramadhas (BD)

Department of Pharmacy, Nyangabgwe Hospital, Francistown, Botswana.

Amanj Kurdi (A)

Strathclyde Institute of Pharmacy and Biomedical Sciences, Strathclyde University, Glasgow, UK.
Department of Pharmacology, College of Pharmacy, Hawler Medical University, Erbil, Iraq.
School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa.

Jacqueline Sneddon (J)

Healthcare Improvement Scotland, Delta House, Glasgow, UK.

Andrew Seaton (A)

Healthcare Improvement Scotland, Delta House, Glasgow, UK.
Queen Elizabeth University Hospital, Glasgow, UK.
University of Glasgow, Glasgow, UK.

Brian Godman (B)

Strathclyde Institute of Pharmacy and Biomedical Sciences, Strathclyde University, Glasgow, UK.
School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa.
School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH